Jerkeman, M <br/><br/>
CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Sep 1999 
 - 1079-86 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1023/a:1008392528248  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bleomycin--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Multivariate Analysis<br/>Prednisolone--administration & dosage<br/>Prognosis<br/>Quality of Life<br/>Survival Rate<br/>Time Factors<br/>Treatment Failure<br/>Vincristine--administration & dosage